Remus Pharmaceuticals Limited is marketing, distributes, and exporting finished formulations of pharmaceutical drugs. The company is backed by expert scientists. The company deals in API and provides technical consultancy services.
Remus is a leading-edge pharmaceutical company fueled by futuristic thinking, focused on improving people’s health by offering a huge array of high-quality, affordable pharmaceutical products. Backed by our expert scientists, state-of-the-art manufacturing facilities, and distributors across the globe, we continue to grow our product portfolio of Active Pharmaceutical Ingredients and Finished Formulations in 40+ countries across major continents.
Objects of the Issue:
- To Meet Working Capital Requirements
- Funding investments for acquisitions and general corporate purposes
- To meet Public Issue Expenses
Remus Pharmaceuticals IPO Review
Date | GMP | Kostak | Subject to |
Today | ₹- | ₹- | ₹- |
9 May | ₹- | ₹- | ₹- |
Remus Pharmaceuticals IPO Date & Price Band Details
IPO Open: | May 17, 2023 |
IPO Close: | May 19, 2023 |
IPO Size: | Approx ₹47.69 Crores, 388,000 Equity Shares |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹1150 to ₹1229 Per Equity Share |
IPO Listing on: | NSE SME |
Retail Quota: | 35% of the net offer |
QIB Quota: | 50% of the net offer |
NII Quota: | 15% of the net offer |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors in IPO: | Click Here |
Remus Pharmaceuticals IPO Market Lot
The Remus Pharmaceuticals IPO minimum market lot is 100 shares with a ₹122,900 application amount.
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 100 | ₹122,900 |
Retail Maximum | 1 | 100 | ₹122,900 |
S-HNI Minimum | 2 | 200 | ₹245,800 |
Remus Pharmaceuticals IPO Dates
The Remus Pharmaceuticals IPO date is May 17 and the IPO close date is May 17. The IPO allotment date is May 24 and the IPO might list on May 29.
IPO Open Date: | May 17, 2023 |
IPO Close Date: | May 19, 2023 |
Basis of Allotment: | May 24, 2023 |
Refunds: | May 25, 2023 |
Credit to Demat Account: | May 26, 2023 |
IPO Listing Date: | May 29, 2023 |
You can check IPO subscription status and IPO allotment status on their respective pages.
Remus Pharmaceuticals IPO Form
How to apply Remus Pharmaceuticals IPO? You can apply Remus Pharmaceuticals IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Remus Pharmaceuticals IPO in the Invest section. The other option you can apply Remus Pharmaceuticals IPO via IPO forms download via the NSE website. Check out the Remus Pharmaceuticals forms – click NSE IPO Forms download, fill and submit in your bank or with your broker.
Remus Pharmaceuticals Company Financial Report
₹ in Crores | |||
Year | Revenue | Expense | PAT |
2020 | ₹12.77 | ₹11.67 | ₹0.81 |
2021 | ₹19.22 | ₹17.87 | ₹1.03 |
2022 | ₹25.44 | ₹20.89 | ₹3.39 |
2023 9M | ₹33.61 | ₹24.92 | ₹6.44 |
Remus Pharmaceuticals IPO Valuation – FY2022
Check Remus Pharmaceuticals IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
Earning Per Share (EPS): | ₹33.86 per Equity Share |
Price/Earning P/E Ratio: | NA |
Return on Net Worth (RoNW): | 52.64% |
Net Asset Value (NAV): | ₹64.3 per Equity Share |
Peer Group
- Trident Lifeline Limited
- Vaishali Pharma Limited
- Chandra Bhagat Pharma Limited
- Mr. Arpit Deepakkumar Shah
- Ms. Roma Vinodbhai Shah
- Mr. Swapnil Jatinbhai Shah
- Mrs. Anar Swapnil Shah
Remus Pharmaceuticals IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://linkintime.co.in/
Remus Pharmaceuticals IPO Allotment Status
Check Remus Pharmaceuticals IPO allotment status on Linkintime website URL. Click Here
Remus Pharmaceuticals IPO Lead Managers aka Merchant Bankers
- Beeline Capital Advisors Pvt Ltd
Company Address
Remus Pharmaceuticals Limited
1101 to 1103, South Tower, One 42,
B/H Ashok Vatika, Nr. Jayantilal Park BRTS,
Ambli bopal Road, Ahmedabad – 380054
Phone: +079- 2999 9857
Email: [email protected]
Website: http://www.remuspharma.com/
Remus Pharmaceuticals IPO FAQs
What is Remus Pharmaceuticals IPO?
Remus Pharmaceuticals IPO is an NSE SME IPO. They are going to raise ₹47.69 Crores via IPO. The issue is priced at ₹1150 to ₹1229 per equity share. The IPO is to be listed on NSE.
When Remus Pharmaceuticals IPO will open?
What is Remus Pharmaceuticals IPO Investors Portion?
How to Apply the Remus Pharmaceuticals IPO?
How to Apply the Remus Pharmaceuticals IPO through Zerodha?
How to Apply the Remus Pharmaceuticals IPO through Upstox?
How to Apply the Remus Pharmaceuticals IPO through Paytm Money?
What is Remus Pharmaceuticals IPO Size?
Remus Pharmaceuticals IPO size is ₹47.69 crores.
What is Remus Pharmaceuticals IPO Price Band?
Remus Pharmaceuticals IPO Price Band is ₹1150 to ₹1229 per equity share.
What is Remus Pharmaceuticals IPO Minimum and Maximum Lot Size?
What is Remus Pharmaceuticals IPO Allotment Date?
What is Remus Pharmaceuticals IPO Listing Date?
Note: The Remus Pharmaceuticals IPO details are announced officially. The IPO grey market premium (Remus Pharmaceuticals IPO Premium) is updated on the respective page. You can check our IPO grey market page for daily updates.)
Follow IPO Watch for the upcoming IPO news and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.
Read Also:
- Remus Pharmaceuticals IPO GMP, Date, Price, Review, Allotment
- Krishca Strapping IPO GMP, Date, Price, Review, Allotment
- Nexus Select Trust IPO Subscription Status – IPO Open
- Nexus Select Trust IPO GMP, Grey Market Premium & Kostak Rates Today
- Nexus Select Trust IPO Date, Review, Price, Allotment, Analysis